ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Reminds Investors of Class Action Against Achillion

  ACHILLION PHARMACEUTICALS, INC. SHAREHOLDER ALERT: Levi & Korsinsky, LLP
  Reminds Investors of Class Action Against Achillion Pharmaceuticals, Inc.
  and Its Board of Directors and a Lead Plaintiff Deadline of December 9, 2013

Business Wire

NEW YORK -- November 22, 2013

Levi & Korsinsky announces that a class action lawsuit has been commenced in
the United States District Court for the District of Connecticut on behalf of
investors who purchased Achillion Pharmaceuticals, Inc. (“Achillion” or the
“Company”) (NasdaqGS: ACHN) common stock between August 8, 2012 and September
30, 2013.

For more information, click here:
http://zlk.9nl.com/achillion-pharmaceuticals-achn/.

The complaint alleges that the Company issued materially false and misleading
statements regarding the safety and suitability of its hepatitis drug
sovaprevir. In particular, it is alleged that Company misled investors
regarding the drug’s interactions with other drugs commonly administered to
treat hepatitis and/or HIV; it is further alleged that the Company misled
investors by stating that elevated liver enzymes in patients engaged in the
clinical trials were transient and related to non-drug-related factors.

On July 1, 2013, the Company disclosed that the FDA had instituted a hold on
sovaprevir after “elevations in liver enzymes” were noted in a Phase I healthy
subject drug-drug interaction study. Then on September 27, 2013, it was
announced that the FDA was maintaining its clinical hold on sovaprevir. Upon
this news, shares of Achillion fell over 58% to a close of $3.02 on September
30, 2013.

If you suffered a loss in Achillion Pharmaceuticals you have until December 9,
2013 to request that the Court appoint you as lead plaintiff. Your ability to
share in any recovery doesn’t require that you serve as a lead plaintiff. To
obtain additional information, contact Joseph E. Levi, Esq. either via email
at jlevi@zlk.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972,
or visit http://zlk.9nl.com/achillion-pharmaceuticals-achn/.

Levi & Korsinsky is a national firm with offices in New York, New Jersey,
Connecticut, and Washington D.C. The firm has extensive expertise in
prosecuting securities litigation involving financial fraud, representing
investors throughout the nation in securities and shareholder lawsuits.
Attorney advertising. Prior results do not guarantee similar outcomes.

Contact:

Levi & Korsinsky, LLP
Joseph Levi, Esq. / Eduard Korsinsky, Esq.
Tel: 212-363-7500
Toll Free: 877-363-5972
Fax: 212-363-7171
www.zlk.com
 
Press spacebar to pause and continue. Press esc to stop.